Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.44)
# 2,318
Out of 4,854 analysts
38
Total ratings
50%
Success rate
0.85%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $4.54
Upside: +98.24%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $37.42
Upside: -19.83%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $74.00
Upside: -13.51%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $16.20
Upside: +4.94%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $56.00
Upside: +12.50%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $70.53
Upside: +53.13%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $63.64
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $176.84
Upside: -21.96%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $108.79
Upside: +29.61%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $46.44
Upside: +35.67%
Initiates: Underperform
Price Target: $42
Current: $41.69
Upside: +0.74%
Initiates: Outperform
Price Target: $41
Current: $31.47
Upside: +30.28%
Initiates: Outperform
Price Target: $29
Current: $32.52
Upside: -10.82%
Initiates: Underperform
Price Target: $74
Current: $62.57
Upside: +18.27%
Initiates: Outperform
Price Target: n/a
Current: $15.36
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.72
Upside: +24.35%
Initiates: Outperform
Price Target: $66
Current: $102.21
Upside: -35.43%
Initiates: Outperform
Price Target: $38
Current: $17.21
Upside: +120.80%
Initiates: Outperform
Price Target: $886
Current: $915.38
Upside: -3.21%
Downgrades: Hold
Price Target: $31$30
Current: $27.39
Upside: +9.53%
Initiates: Buy
Price Target: $21
Current: $10.86
Upside: +93.37%
Downgrades: Hold
Price Target: $21$25
Current: $9.79
Upside: +155.36%
Upgrades: Buy
Price Target: n/a
Current: $25.28
Upside: -